If pharma can do it (for now only rumor), what is so difficult for bios?
I will first reduce (in third) options vesting period, reduced options and fat bonuses award. So, they may change their broken record tomorrow, or the sooner the better.
Miljenko
Saturday April 21, 5:33 pm Eastern Time
GlaxoSmithKline seen eyeing U.S. drugs firm-paper
LONDON, April 21 (Reuters) - British pharmaceuticals giant GlaxoSmithKline (quote from Yahoo! UK & Ireland: GSK.L) is considering starting talks about a 150 billion pound ($216.5 billion) merger with U.S. drugs firm American Home Products Corp (NYSE:AHP - news), a newspaper reported on Sunday.
Britain's Sunday Observer quoted GSK ``company insiders'' as saying that the company's Chief Executive Jean-Pierre Garnier had charged a high-level task force with finding targets and AHP was Garnier's favoured U.S. target for his next big deal.
GSK spokesman Martin Sutton told Reuters when asked about the report: ``We never comment on rumour and speculation.''
Industry sources said they were sceptical that such a deal was imminent as GSK still had enough to deal with after the merger between Glaxo Wellcome and SmithKline Beecham that formed GSK at the end of last year.
Garnier said in February that GlaxoSmithKline was ready to make acquisitions to build the drugmaker's pipeline of new products.
An earlier attempt to merge AHP with SmithKline Beecham, before the deal forming GSK, failed.
``Garnier still admires AHP greatly from his SmithKline days,'' one GSK insider was quoted by the Observer as saying.
``The two fit like a glove, strong in vaccines and consumer products. AHP also has a good new drugs pipeline while Glaxo and SmithKline's have been relatively weak,'' the insider added. |
